JP2022024034A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022024034A5 JP2022024034A5 JP2021183553A JP2021183553A JP2022024034A5 JP 2022024034 A5 JP2022024034 A5 JP 2022024034A5 JP 2021183553 A JP2021183553 A JP 2021183553A JP 2021183553 A JP2021183553 A JP 2021183553A JP 2022024034 A5 JP2022024034 A5 JP 2022024034A5
- Authority
- JP
- Japan
- Prior art keywords
- drawings
- present application
- invention described
- application
- present
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025041552A JP2025085744A (ja) | 2018-12-28 | 2025-03-14 | ピロリジン化合物の結晶 |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2018247437 | 2018-12-28 | ||
| JP2018247437 | 2018-12-28 | ||
| JP2020562542A JP6977185B2 (ja) | 2018-12-28 | 2019-12-27 | ピロリジン化合物の結晶 |
| PCT/JP2019/051570 WO2020138481A1 (ja) | 2018-12-28 | 2019-12-27 | ピロリジン化合物の結晶 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020562542A Division JP6977185B2 (ja) | 2018-12-28 | 2019-12-27 | ピロリジン化合物の結晶 |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025041552A Division JP2025085744A (ja) | 2018-12-28 | 2025-03-14 | ピロリジン化合物の結晶 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022024034A JP2022024034A (ja) | 2022-02-08 |
| JP2022024034A5 true JP2022024034A5 (enExample) | 2023-01-10 |
| JP7652682B2 JP7652682B2 (ja) | 2025-03-27 |
Family
ID=71127176
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020562542A Active JP6977185B2 (ja) | 2018-12-28 | 2019-12-27 | ピロリジン化合物の結晶 |
| JP2021183553A Active JP7652682B2 (ja) | 2018-12-28 | 2021-11-10 | ピロリジン化合物の結晶 |
| JP2025041552A Pending JP2025085744A (ja) | 2018-12-28 | 2025-03-14 | ピロリジン化合物の結晶 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020562542A Active JP6977185B2 (ja) | 2018-12-28 | 2019-12-27 | ピロリジン化合物の結晶 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025041552A Pending JP2025085744A (ja) | 2018-12-28 | 2025-03-14 | ピロリジン化合物の結晶 |
Country Status (8)
| Country | Link |
|---|---|
| US (2) | US12077524B2 (enExample) |
| EP (4) | EP3903785B1 (enExample) |
| JP (3) | JP6977185B2 (enExample) |
| CN (3) | CN120081826A (enExample) |
| ES (1) | ES2991904T3 (enExample) |
| MA (1) | MA54619A (enExample) |
| TW (3) | TWI834791B (enExample) |
| WO (1) | WO2020138481A1 (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR122595A1 (es) | 2020-06-10 | 2022-09-21 | Mitsubishi Tanabe Pharma Corp | Agente profiláctico o terapéutico para fotodermatosis |
| KR102952931B1 (ko) | 2020-06-10 | 2026-04-15 | 다나베 파마 가부시키가이샤 | 포르피린증의 예방 또는 치료제 |
| CN122557552A (zh) * | 2020-06-10 | 2026-08-14 | 田边制药株式会社 | 卟啉症的预防或治疗剂 |
| CN117255786A (zh) * | 2021-05-06 | 2023-12-19 | 株式会社Lg 化学 | 黑皮质素受体激动剂化合物的晶型vii及其制备方法 |
| KR102854595B1 (ko) * | 2021-05-06 | 2025-09-03 | 주식회사 엘지화학 | 멜라노코르틴 수용체 작용제 화합물의 결정형 v 및 이의 제조방법 |
| KR102854598B1 (ko) * | 2021-05-07 | 2025-09-03 | 주식회사 엘지화학 | 멜라노코르틴 수용체 작용제 화합물의 황산염의 결정형 및 이의 제조방법 |
| JP2024517271A (ja) * | 2021-05-07 | 2024-04-19 | エルジー・ケム・リミテッド | メラノコルチン受容体アゴニスト化合物の有機酸塩の結晶形ｉｖおよびその製造方法 |
| US20240239769A1 (en) * | 2021-05-07 | 2024-07-18 | Lg Chem, Ltd. | Co-crystal of melanocortin receptor agonist compound and vanillin and method for preparing same |
| KR20240145490A (ko) | 2022-01-31 | 2024-10-07 | 미쓰비시 타나베 파마 코퍼레이션 | 멜라노코르틴 1 수용체 아고니스트의 신규 용도 |
| WO2024029599A1 (ja) | 2022-08-03 | 2024-02-08 | 田辺三菱製薬株式会社 | １－｛２－［（３ｓ，４ｒ）－１－｛［（３ｒ，４ｒ）－１－シクロペンチル－３－フルオロ－４－（４－メトキシフェニル）ピロリジン－３－イル］カルボニル｝－４－（メトキシメチル）ピロリジン－３－イル］－５－（トリフルオロメチル）フェニル｝ピペリジン－４－カルボン酸もしくはその医薬的に許容し得る塩又は共結晶を含有する医薬組成物 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2005283326B2 (en) | 2004-09-13 | 2011-07-21 | Ono Pharmaceutical Co., Ltd. | Nitrogenous heterocyclic derivative and medicine containing the same as an active ingredient |
| EP1951286A4 (en) * | 2005-10-07 | 2009-11-04 | Waratah Pharmaceuticals Inc | COMBINED USE OF INHIBITORS OF DPP-IV AND GASTRIN COMPOUNDS |
| PT3150578T (pt) * | 2014-05-29 | 2021-01-18 | Mitsubishi Tanabe Pharma Corp | Novo composto de pirrolidina e aplicação como agonista do recetor de melanocortina |
| JP6392297B2 (ja) * | 2015-11-27 | 2018-09-19 | 田辺三菱製薬株式会社 | 医薬組成物 |
-
2019
- 2019-12-27 CN CN202510224370.1A patent/CN120081826A/zh active Pending
- 2019-12-27 MA MA054619A patent/MA54619A/fr unknown
- 2019-12-27 TW TW108148109A patent/TWI834791B/zh active
- 2019-12-27 EP EP19905349.7A patent/EP3903785B1/en active Active
- 2019-12-27 CN CN201980086473.9A patent/CN113226314B/zh active Active
- 2019-12-27 WO PCT/JP2019/051570 patent/WO2020138481A1/ja not_active Ceased
- 2019-12-27 ES ES19905349T patent/ES2991904T3/es active Active
- 2019-12-27 CN CN202510225181.6A patent/CN120081827A/zh active Pending
- 2019-12-27 TW TW113104509A patent/TWI870228B/zh active
- 2019-12-27 EP EP26175127.5A patent/EP4763282A2/en active Pending
- 2019-12-27 JP JP2020562542A patent/JP6977185B2/ja active Active
- 2019-12-27 US US17/418,563 patent/US12077524B2/en active Active
- 2019-12-27 EP EP25183270.5A patent/EP4603143A3/en active Pending
- 2019-12-27 TW TW113147267A patent/TWI919623B/zh active
- 2019-12-27 EP EP24193769.7A patent/EP4434582A3/en not_active Withdrawn
-
2021
- 2021-11-10 JP JP2021183553A patent/JP7652682B2/ja active Active
-
2024
- 2024-07-23 US US18/781,544 patent/US20250002474A1/en active Pending
-
2025
- 2025-03-14 JP JP2025041552A patent/JP2025085744A/ja active Pending